dpp4 and glp-1 Neuroprotection by dipeptidyl-peptidase-4 inhibitors glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer's disease Cardiovascular effects of DPP-4 inhibition:

Clients recieving Medicare and Medicaid coverage could soon see lower prices for these medications.

Ellie MDs Black Friday Sale is live for the next 7 days only

- - - A new Oxford meta-analysis (P04.009, EASO 2025) confirms what many clinicians have observed: stopping GLP-1 receptor agonists often leads to rapid and near-complete weight regain within 12 years

Youve probably heard about the dramatic weight loss that can happen when you take Ozempic or Wegovy

GLP-1(936) retained its glucagonostatic effects after genetic/pharmacological inactivation of the GLP-1 receptor

GLP-1 drugs are quickly becoming some of the most ubiquitous in the U.S., and they have drawn interest for their potential use in treating alcohol use disorder.